Pfizer
-
Ritlecitinib, taken once a day, approved by Nice for severe hair loss caused by autoimmune disease
-
Dr David Brown says erectile dysfunction drug, subject of a BBC drama, could have been scrapped if a miner hadn’t spoken out
-
State attorney general Ken Paxton files suit despite medical consensus that vaccine prevents severe infection and death
-
Biden administration urged to declare a public health emergency with key medication for preventable condition in short supply
-
Democrats say deaths will follow false claim by Dr Joseph Ladapo that new boosters were not tested on humans
-
Health officials reiterate support for private provision as lower age limit for NHS booster vaccines raised to 65
-
Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest
-
Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results
-
The pharma giant’s UK chief is adding the company’s voice to scientists’ warnings of the dangers of antibacterial resistance
-
The move to end the declarations comes as House Republicans are set to pass a resolution to demand their immediate scrapping
-
The FDA asked its scientific advisers on Thursday to help chalk out plan to move to a flu shot-like schedule for coronavirus
-
WHO says the strains are not different enough to label them variants of concern but experts urge staying up to date with vaccines
-
Uğur Şahin and Özlem Türeci say mRNA Covid vaccine technology could be repurposed to help destroy cancer cells
-
Company is suing pharmaceutical rival and its German partner for patent infringement
-
Penalties come after an in-depth investigation carried out by the Competition and Markets Authority
-
Company launches ‘healthier world’ accord in Davos and speaks to other pharma firms about similar steps